Leeward Investments LLC MA Has $4.28 Million Stock Holdings in Humana Inc. (NYSE:HUM)

Leeward Investments LLC MA lowered its holdings in shares of Humana Inc. (NYSE:HUM) by 52.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 16,885 shares of the insurance provider’s stock after selling 18,430 shares during the period. Leeward Investments LLC MA’s holdings in Humana were worth $4,284,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Creative Financial Designs Inc. ADV raised its position in Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 61 shares during the last quarter. FPC Investment Advisory Inc. acquired a new stake in shares of Humana in the fourth quarter valued at about $27,000. Centricity Wealth Management LLC bought a new position in shares of Humana during the fourth quarter worth about $30,000. Ashton Thomas Securities LLC acquired a new position in shares of Humana in the third quarter worth approximately $31,000. Finally, Your Advocates Ltd. LLP boosted its holdings in Humana by 81.8% in the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after acquiring an additional 45 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Insider Transactions at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.32% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of analyst reports. Morgan Stanley reduced their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 12th. Piper Sandler lifted their price objective on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. Barclays raised their target price on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. Wells Fargo & Company dropped their price target on Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research note on Tuesday, February 18th. Nineteen research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, Humana has a consensus rating of “Hold” and a consensus price target of $285.68.

Humana Stock Down 5.7 %

Shares of NYSE:HUM opened at $255.77 on Monday. The business’s 50 day moving average is $269.41 and its 200 day moving average is $289.61. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46. The stock has a market cap of $30.80 billion, a price-to-earnings ratio of 25.71, a PEG ratio of 2.05 and a beta of 0.56. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.38%. Humana’s dividend payout ratio is currently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.